Antibiotic composition

Details for Australian Patent Application No. 2003218024 (hide)

Owner Advancis Pharmaceuticals Corporation

Inventors Rudnic, Edward M; Treacy, Jr Donald J; Wassink, Sandra E; Isbister, James D

Agent Spruson & Ferguson

Pub. Number AU-B-2003218024

PCT Number PCT/US03/07118

PCT Pub. Number WO2003/075852

Priority 10/093,214 07.03.02 US; 10/092,858 07.03.02 US; 10/092,811 07.03.02 US; 10/092,854 07.03.02 US; 10/093,321 07.03.02 US

Filing date 7 March 2003

Wipo publication date 22 September 2003

Acceptance publication date 11 September 2008

International Classifications

A61K 31/7048 (2006.01)

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/26 (2006.01) Medicinal preparations characterised by special physical form - Discrete particles in supporting matrix

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/43 (2006.01)

A61K 31/431 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/65 (2006.01) - Tetracyclines

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 10/093,214 07.03.02 US; 10/092,858 07.03.02 US; 10/092,811 07.03.02 US; 10/092,854 07.03.02 US; 10/093,321 07.03.02 US

30 October 2003 Application Open to Public Inspection

  Published as AU-B-2003218024

11 September 2008 Application Accepted

  Published as AU-B-2003218024

23 October 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 24 Sep 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

12 February 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 24 Sep 2008

19 February 2009 Standard Patent Sealed

2 April 2009 Alteration of Name

  The name of the patentee has been altered to MiddleBrook Pharmaceuticals, Inc.

21 April 2011 Assignment Registered

  MiddleBrook Pharmaceuticals, Inc. The patent has been assigned to Victory Pharma, Inc.

20 October 2011 Assignment Registered

  Victory Pharma, Inc. The patent has been assigned to Shionogi, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003218025-ANALYSIS OF APOPTOTIC BODIES IN BODILY FLUIDS

2003218023-HYDROCARBON HYDROGENATION CATALYST COMPOSITION, A PROCESS OF TREATING SUCH CATALYST COMPOSITION, AND A PROCESS OF USING SUCH CATALYST COMPOSITION